| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurosurgical Procedures | 12 | 2017 | 231 | 3.750 |
Why?
|
| Hydrocephalus | 7 | 2016 | 104 | 2.560 |
Why?
|
| Postoperative Complications | 16 | 2018 | 2285 | 2.310 |
Why?
|
| Spinal Fusion | 10 | 2018 | 86 | 2.290 |
Why?
|
| Craniosynostoses | 5 | 2017 | 77 | 2.250 |
Why?
|
| Third Ventricle | 4 | 2016 | 13 | 2.060 |
Why?
|
| Spinal Cord Neoplasms | 5 | 2015 | 47 | 2.010 |
Why?
|
| Neuroendoscopy | 5 | 2016 | 18 | 1.760 |
Why?
|
| Databases, Factual | 15 | 2018 | 846 | 1.730 |
Why?
|
| Ventriculostomy | 4 | 2016 | 26 | 1.650 |
Why?
|
| Infant | 31 | 2017 | 3117 | 1.640 |
Why?
|
| Arnold-Chiari Malformation | 4 | 2016 | 43 | 1.550 |
Why?
|
| Meningomyelocele | 3 | 2016 | 22 | 1.510 |
Why?
|
| Ventriculoperitoneal Shunt | 3 | 2016 | 24 | 1.460 |
Why?
|
| Adolescent | 43 | 2017 | 9157 | 1.350 |
Why?
|
| Hospitalization | 7 | 2017 | 871 | 1.350 |
Why?
|
| Astrocytoma | 3 | 2014 | 82 | 1.340 |
Why?
|
| Male | 85 | 2018 | 42012 | 1.300 |
Why?
|
| Cerebrospinal Fluid Shunts | 4 | 2015 | 52 | 1.290 |
Why?
|
| Craniotomy | 5 | 2016 | 88 | 1.260 |
Why?
|
| Female | 85 | 2018 | 45759 | 1.210 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2017 | 77 | 1.170 |
Why?
|
| Plagiocephaly, Nonsynostotic | 2 | 2017 | 3 | 1.160 |
Why?
|
| Orthotic Devices | 2 | 2017 | 9 | 1.160 |
Why?
|
| Spinal Diseases | 4 | 2018 | 44 | 1.160 |
Why?
|
| Child, Preschool | 26 | 2017 | 3678 | 1.150 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2017 | 10 | 1.120 |
Why?
|
| Child | 34 | 2017 | 7089 | 1.120 |
Why?
|
| Spine | 4 | 2015 | 102 | 1.090 |
Why?
|
| Skull | 5 | 2015 | 253 | 1.070 |
Why?
|
| Surgical Wound Infection | 6 | 2018 | 199 | 1.070 |
Why?
|
| Anti-Bacterial Agents | 8 | 2017 | 777 | 1.050 |
Why?
|
| Decompression, Surgical | 7 | 2016 | 87 | 1.040 |
Why?
|
| Cervical Vertebrae | 10 | 2018 | 81 | 1.020 |
Why?
|
| Ependymoma | 2 | 2015 | 17 | 1.010 |
Why?
|
| Humans | 103 | 2018 | 88611 | 1.000 |
Why?
|
| Hospital Costs | 2 | 2016 | 107 | 0.990 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2015 | 48 | 0.970 |
Why?
|
| Treatment Outcome | 30 | 2018 | 8178 | 0.900 |
Why?
|
| Helicobacter Infections | 6 | 2003 | 36 | 0.860 |
Why?
|
| Helicobacter pylori | 6 | 2003 | 36 | 0.860 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 322 | 0.850 |
Why?
|
| Duodenal Ulcer | 6 | 2003 | 11 | 0.840 |
Why?
|
| Retrospective Studies | 32 | 2018 | 8893 | 0.770 |
Why?
|
| Reoperation | 4 | 2016 | 605 | 0.760 |
Why?
|
| Epilepsy | 2 | 2016 | 421 | 0.760 |
Why?
|
| Young Adult | 16 | 2016 | 6218 | 0.750 |
Why?
|
| Pediatrics | 4 | 2017 | 351 | 0.730 |
Why?
|
| United States | 14 | 2016 | 6882 | 0.730 |
Why?
|
| Quality Improvement | 4 | 2017 | 443 | 0.720 |
Why?
|
| Infant, Newborn | 13 | 2017 | 2445 | 0.720 |
Why?
|
| Length of Stay | 11 | 2017 | 726 | 0.700 |
Why?
|
| Registries | 2 | 2014 | 759 | 0.690 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2015 | 597 | 0.670 |
Why?
|
| Frontal Bone | 2 | 2015 | 16 | 0.650 |
Why?
|
| Craniocerebral Trauma | 2 | 2017 | 54 | 0.640 |
Why?
|
| Follow-Up Studies | 15 | 2017 | 3655 | 0.630 |
Why?
|
| Cranial Fossa, Posterior | 2 | 2016 | 25 | 0.630 |
Why?
|
| Airway Obstruction | 2 | 2016 | 110 | 0.620 |
Why?
|
| Hematoma | 2 | 2015 | 107 | 0.600 |
Why?
|
| Mydriasis | 1 | 2017 | 2 | 0.600 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2017 | 8 | 0.590 |
Why?
|
| Middle Aged | 42 | 2018 | 25699 | 0.580 |
Why?
|
| Craniopharyngioma | 1 | 2017 | 12 | 0.580 |
Why?
|
| Spinal Neoplasms | 2 | 2014 | 48 | 0.580 |
Why?
|
| Tuberculosis, Oral | 1 | 2016 | 1 | 0.560 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2016 | 5 | 0.560 |
Why?
|
| Sialadenitis | 1 | 2016 | 8 | 0.560 |
Why?
|
| Cohort Studies | 8 | 2018 | 2837 | 0.550 |
Why?
|
| Pituitary Neoplasms | 1 | 2017 | 69 | 0.550 |
Why?
|
| Aortic Diseases | 1 | 2017 | 99 | 0.550 |
Why?
|
| Airway Extubation | 1 | 2016 | 13 | 0.550 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 143 | 0.550 |
Why?
|
| Physical Therapy Modalities | 1 | 2017 | 83 | 0.550 |
Why?
|
| Inpatients | 2 | 2018 | 308 | 0.540 |
Why?
|
| Risk Factors | 13 | 2018 | 5449 | 0.540 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 157 | 0.540 |
Why?
|
| Fever | 2 | 2015 | 127 | 0.530 |
Why?
|
| Seasons | 1 | 2017 | 233 | 0.530 |
Why?
|
| Orbital Cellulitis | 1 | 2015 | 4 | 0.530 |
Why?
|
| Neurocysticercosis | 1 | 2015 | 6 | 0.530 |
Why?
|
| Aged | 38 | 2018 | 18932 | 0.530 |
Why?
|
| Sphenoid Bone | 1 | 2015 | 9 | 0.530 |
Why?
|
| Patient Compliance | 2 | 2017 | 228 | 0.520 |
Why?
|
| Eye Infections, Bacterial | 1 | 2015 | 15 | 0.520 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2015 | 865 | 0.510 |
Why?
|
| Cranial Sutures | 1 | 2015 | 47 | 0.510 |
Why?
|
| Age Factors | 12 | 2015 | 1863 | 0.510 |
Why?
|
| Perioperative Care | 1 | 2017 | 167 | 0.510 |
Why?
|
| Encephalitis | 1 | 2015 | 104 | 0.510 |
Why?
|
| Hemispherectomy | 1 | 2014 | 3 | 0.500 |
Why?
|
| Papilloma, Choroid Plexus | 1 | 2014 | 1 | 0.500 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 2014 | 2 | 0.500 |
Why?
|
| Electrodes, Implanted | 1 | 2016 | 177 | 0.500 |
Why?
|
| Pneumococcal Infections | 1 | 2015 | 47 | 0.500 |
Why?
|
| Neurosurgery | 2 | 2016 | 97 | 0.500 |
Why?
|
| Hamartoma | 1 | 2015 | 34 | 0.500 |
Why?
|
| Cerebral Aqueduct | 1 | 2014 | 1 | 0.500 |
Why?
|
| Neural Crest | 1 | 2015 | 32 | 0.490 |
Why?
|
| Venous Thromboembolism | 2 | 2015 | 158 | 0.490 |
Why?
|
| Spina Bifida Occulta | 1 | 2014 | 6 | 0.490 |
Why?
|
| Brain Injuries | 2 | 2014 | 163 | 0.490 |
Why?
|
| Dermoid Cyst | 1 | 2014 | 15 | 0.490 |
Why?
|
| Adult | 37 | 2018 | 26348 | 0.480 |
Why?
|
| Models, Economic | 1 | 2014 | 60 | 0.480 |
Why?
|
| Blood Transfusion | 2 | 2015 | 164 | 0.480 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 155 | 0.480 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 179 | 0.470 |
Why?
|
| Lumbar Vertebrae | 4 | 2016 | 151 | 0.470 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2014 | 19 | 0.470 |
Why?
|
| Brain Stem Neoplasms | 1 | 2014 | 17 | 0.470 |
Why?
|
| Infant, Premature, Diseases | 1 | 2014 | 78 | 0.460 |
Why?
|
| Laminectomy | 2 | 2014 | 27 | 0.460 |
Why?
|
| Syringomyelia | 3 | 2012 | 14 | 0.460 |
Why?
|
| Hyperhidrosis | 1 | 2013 | 10 | 0.450 |
Why?
|
| Psoas Abscess | 1 | 2013 | 2 | 0.450 |
Why?
|
| Decompressive Craniectomy | 1 | 2013 | 18 | 0.440 |
Why?
|
| Meconium | 1 | 2012 | 15 | 0.430 |
Why?
|
| Transplantation, Autologous | 1 | 2014 | 342 | 0.430 |
Why?
|
| Glioblastoma | 1 | 2015 | 265 | 0.430 |
Why?
|
| Prospective Studies | 14 | 2016 | 4271 | 0.420 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 198 | 0.420 |
Why?
|
| Deep Brain Stimulation | 1 | 2013 | 61 | 0.420 |
Why?
|
| Multivariate Analysis | 5 | 2015 | 995 | 0.420 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 328 | 0.410 |
Why?
|
| Occipital Bone | 4 | 2015 | 18 | 0.410 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 525 | 0.410 |
Why?
|
| Population Surveillance | 1 | 2013 | 217 | 0.410 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2017 | 595 | 0.400 |
Why?
|
| Brain Stem | 1 | 2012 | 167 | 0.400 |
Why?
|
| Parkinson Disease | 1 | 2013 | 143 | 0.400 |
Why?
|
| Carcinoma | 1 | 2014 | 441 | 0.380 |
Why?
|
| Drug Therapy, Combination | 4 | 2017 | 799 | 0.370 |
Why?
|
| Peptic Ulcer Hemorrhage | 4 | 2000 | 10 | 0.360 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 396 | 0.360 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 268 | 0.360 |
Why?
|
| Time Factors | 8 | 2018 | 5319 | 0.360 |
Why?
|
| Thoracic Vertebrae | 4 | 2015 | 51 | 0.360 |
Why?
|
| Prognosis | 10 | 2015 | 3750 | 0.360 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 274 | 0.350 |
Why?
|
| Diagnosis, Differential | 6 | 2016 | 1588 | 0.350 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 350 | 0.350 |
Why?
|
| SEER Program | 3 | 2015 | 197 | 0.350 |
Why?
|
| Brain | 2 | 2017 | 2268 | 0.340 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 779 | 0.340 |
Why?
|
| Patient Readmission | 3 | 2018 | 349 | 0.330 |
Why?
|
| Stomach Ulcer | 3 | 2003 | 23 | 0.290 |
Why?
|
| Diskectomy | 3 | 2018 | 20 | 0.290 |
Why?
|
| Bone Transplantation | 4 | 2015 | 66 | 0.290 |
Why?
|
| Computer-Aided Design | 1 | 2017 | 17 | 0.290 |
Why?
|
| Aged, 80 and over | 15 | 2016 | 6723 | 0.290 |
Why?
|
| Incidence | 4 | 2016 | 1592 | 0.290 |
Why?
|
| Endoscopy, Gastrointestinal | 5 | 2003 | 156 | 0.290 |
Why?
|
| Parietal Bone | 3 | 2016 | 20 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2016 | 2638 | 0.270 |
Why?
|
| Minimally Invasive Surgical Procedures | 4 | 2015 | 251 | 0.270 |
Why?
|
| Scalp | 2 | 2017 | 72 | 0.270 |
Why?
|
| Survival Rate | 4 | 2014 | 1883 | 0.260 |
Why?
|
| Omeprazole | 2 | 2003 | 11 | 0.260 |
Why?
|
| Anti-Ulcer Agents | 2 | 2003 | 22 | 0.260 |
Why?
|
| Spinal Cord Compression | 2 | 2015 | 27 | 0.250 |
Why?
|
| Spondylolisthesis | 2 | 2015 | 12 | 0.250 |
Why?
|
| Skull Fractures | 2 | 2015 | 24 | 0.250 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 1694 | 0.250 |
Why?
|
| Intervertebral Disc Degeneration | 2 | 2015 | 7 | 0.240 |
Why?
|
| Hong Kong | 6 | 2013 | 45 | 0.240 |
Why?
|
| Surveys and Questionnaires | 6 | 2015 | 2593 | 0.240 |
Why?
|
| Disability Evaluation | 3 | 2013 | 138 | 0.240 |
Why?
|
| Publishing | 2 | 2016 | 91 | 0.240 |
Why?
|
| Odds Ratio | 3 | 2015 | 686 | 0.230 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2015 | 295 | 0.230 |
Why?
|
| Spondylosis | 2 | 2013 | 4 | 0.230 |
Why?
|
| Spinal Fractures | 2 | 2014 | 76 | 0.230 |
Why?
|
| Pain Measurement | 3 | 2013 | 329 | 0.230 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 367 | 0.220 |
Why?
|
| Sex Factors | 4 | 2015 | 1063 | 0.210 |
Why?
|
| Logistic Models | 3 | 2015 | 1205 | 0.210 |
Why?
|
| Esophagitis, Peptic | 1 | 2002 | 10 | 0.210 |
Why?
|
| Chest Pain | 1 | 2002 | 43 | 0.200 |
Why?
|
| Cholangitis | 1 | 2001 | 19 | 0.200 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2001 | 63 | 0.200 |
Why?
|
| Quality of Life | 5 | 2017 | 1649 | 0.190 |
Why?
|
| Emergencies | 2 | 2001 | 118 | 0.190 |
Why?
|
| Benzimidazoles | 1 | 2001 | 113 | 0.190 |
Why?
|
| Antacids | 1 | 2000 | 4 | 0.190 |
Why?
|
| Pain | 2 | 2013 | 401 | 0.180 |
Why?
|
| Blood Loss, Surgical | 3 | 2015 | 115 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2017 | 3445 | 0.180 |
Why?
|
| Gastroesophageal Reflux | 1 | 2002 | 121 | 0.180 |
Why?
|
| Neoplasm Staging | 4 | 2014 | 1983 | 0.170 |
Why?
|
| Operative Time | 2 | 2016 | 138 | 0.160 |
Why?
|
| Outpatients | 1 | 2018 | 98 | 0.150 |
Why?
|
| ROC Curve | 3 | 2014 | 773 | 0.140 |
Why?
|
| Treatment Failure | 2 | 2014 | 289 | 0.140 |
Why?
|
| Actins | 2 | 2017 | 456 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2003 | 242 | 0.140 |
Why?
|
| Gonadal Dysgenesis | 1 | 1996 | 3 | 0.140 |
Why?
|
| Cystadenoma, Mucinous | 1 | 1996 | 7 | 0.140 |
Why?
|
| Bibliometrics | 1 | 2016 | 37 | 0.140 |
Why?
|
| Fasciitis | 1 | 2016 | 10 | 0.130 |
Why?
|
| Baclofen | 1 | 2015 | 15 | 0.130 |
Why?
|
| Muscle Relaxants, Central | 1 | 2015 | 10 | 0.130 |
Why?
|
| Anthelmintics | 1 | 2015 | 6 | 0.130 |
Why?
|
| Microsurgery | 2 | 2013 | 88 | 0.130 |
Why?
|
| After-Hours Care | 1 | 2015 | 8 | 0.130 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 1020 | 0.130 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2016 | 49 | 0.130 |
Why?
|
| Forehead | 1 | 2015 | 15 | 0.130 |
Why?
|
| Amygdala | 1 | 2016 | 86 | 0.130 |
Why?
|
| Esthetics | 1 | 2015 | 45 | 0.130 |
Why?
|
| Enoxaparin | 1 | 2015 | 23 | 0.130 |
Why?
|
| Airway Management | 1 | 2016 | 46 | 0.130 |
Why?
|
| Health Facility Size | 1 | 2015 | 9 | 0.130 |
Why?
|
| Orbit | 1 | 2015 | 38 | 0.130 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2015 | 30 | 0.130 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2015 | 16 | 0.130 |
Why?
|
| Specialties, Surgical | 1 | 2016 | 65 | 0.130 |
Why?
|
| Health Care Costs | 2 | 2016 | 235 | 0.130 |
Why?
|
| Elective Surgical Procedures | 1 | 2016 | 126 | 0.130 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2015 | 127 | 0.130 |
Why?
|
| Accidental Falls | 1 | 2015 | 51 | 0.120 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 360 | 0.120 |
Why?
|
| Spinal Curvatures | 1 | 2014 | 7 | 0.120 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 109 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 837 | 0.120 |
Why?
|
| Primary Prevention | 1 | 2015 | 80 | 0.120 |
Why?
|
| Cysts | 1 | 2015 | 106 | 0.120 |
Why?
|
| Dyspnea | 1 | 2015 | 75 | 0.120 |
Why?
|
| Social Class | 1 | 2015 | 134 | 0.120 |
Why?
|
| Neural Tube Defects | 1 | 2014 | 43 | 0.120 |
Why?
|
| Free Tissue Flaps | 1 | 2015 | 49 | 0.120 |
Why?
|
| Vertebroplasty | 1 | 2014 | 8 | 0.120 |
Why?
|
| Meningitis | 2 | 2015 | 20 | 0.120 |
Why?
|
| Vancomycin | 1 | 2014 | 73 | 0.120 |
Why?
|
| Venous Cutdown | 1 | 2014 | 2 | 0.120 |
Why?
|
| Geography | 1 | 2015 | 228 | 0.120 |
Why?
|
| Body Height | 1 | 2014 | 100 | 0.120 |
Why?
|
| Bone Matrix | 1 | 2014 | 19 | 0.120 |
Why?
|
| Fractures, Compression | 1 | 2014 | 17 | 0.120 |
Why?
|
| History, 19th Century | 1 | 2014 | 56 | 0.120 |
Why?
|
| Community Health Planning | 1 | 2014 | 21 | 0.120 |
Why?
|
| Amoxicillin | 3 | 2003 | 13 | 0.120 |
Why?
|
| Insurance, Health | 1 | 2015 | 160 | 0.120 |
Why?
|
| Patient Acuity | 1 | 2014 | 33 | 0.120 |
Why?
|
| Hemangioma | 1 | 2014 | 64 | 0.120 |
Why?
|
| Spinal Cord | 1 | 2015 | 255 | 0.120 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 218 | 0.110 |
Why?
|
| Patient Discharge | 1 | 1997 | 318 | 0.110 |
Why?
|
| Head Injuries, Closed | 1 | 2013 | 11 | 0.110 |
Why?
|
| Deglutition Disorders | 1 | 2015 | 119 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1851 | 0.110 |
Why?
|
| Temporal Bone | 1 | 2014 | 66 | 0.110 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 188 | 0.110 |
Why?
|
| Spinal Cord Diseases | 1 | 2013 | 29 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2014 | 177 | 0.110 |
Why?
|
| Internet | 1 | 2015 | 318 | 0.110 |
Why?
|
| Foraminotomy | 1 | 2012 | 2 | 0.110 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2017 | 20 | 0.110 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2012 | 22 | 0.110 |
Why?
|
| Respiratory Paralysis | 1 | 2012 | 8 | 0.110 |
Why?
|
| Models, Statistical | 1 | 2016 | 575 | 0.110 |
Why?
|
| Spinal Stenosis | 1 | 2012 | 25 | 0.110 |
Why?
|
| Vocal Cord Paralysis | 1 | 2012 | 27 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2014 | 307 | 0.110 |
Why?
|
| Hippocampus | 1 | 2016 | 446 | 0.110 |
Why?
|
| Laryngoscopy | 1 | 2012 | 44 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 356 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2016 | 563 | 0.100 |
Why?
|
| Tracheostomy | 1 | 2012 | 45 | 0.100 |
Why?
|
| Enteral Nutrition | 1 | 2012 | 102 | 0.100 |
Why?
|
| Self Report | 1 | 2014 | 294 | 0.100 |
Why?
|
| Gastrostomy | 1 | 2012 | 69 | 0.100 |
Why?
|
| Disabled Persons | 1 | 2013 | 72 | 0.100 |
Why?
|
| Metronidazole | 2 | 2003 | 26 | 0.100 |
Why?
|
| Medulla Oblongata | 1 | 2012 | 91 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2015 | 423 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 1213 | 0.100 |
Why?
|
| Bites and Stings | 1 | 2011 | 9 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2014 | 902 | 0.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 186 | 0.100 |
Why?
|
| Arthropods | 1 | 2011 | 28 | 0.100 |
Why?
|
| Anemia, Hypochromic | 1 | 1991 | 5 | 0.100 |
Why?
|
| Surgical Flaps | 1 | 2013 | 249 | 0.090 |
Why?
|
| Hospital Mortality | 1 | 2013 | 381 | 0.090 |
Why?
|
| Urban Population | 2 | 2002 | 223 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 577 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 460 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2013 | 389 | 0.090 |
Why?
|
| Eosinophilia | 1 | 1990 | 85 | 0.080 |
Why?
|
| Employee Performance Appraisal | 1 | 2009 | 4 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 1996 | 759 | 0.080 |
Why?
|
| Subarachnoid Space | 1 | 2008 | 17 | 0.080 |
Why?
|
| Family Practice | 1 | 2009 | 85 | 0.080 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 1709 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2009 | 146 | 0.070 |
Why?
|
| Antibodies, Viral | 2 | 1985 | 306 | 0.070 |
Why?
|
| Biometry | 1 | 2017 | 66 | 0.070 |
Why?
|
| Obesity | 1 | 2013 | 972 | 0.070 |
Why?
|
| Clarithromycin | 2 | 2003 | 7 | 0.070 |
Why?
|
| Dyspepsia | 2 | 2003 | 10 | 0.070 |
Why?
|
| Measles | 1 | 1985 | 16 | 0.070 |
Why?
|
| Measles Vaccine | 1 | 1985 | 8 | 0.070 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 2 | 2003 | 4 | 0.070 |
Why?
|
| Texas | 2 | 2015 | 108 | 0.060 |
Why?
|
| Immunization | 1 | 1985 | 160 | 0.060 |
Why?
|
| Cerebellum | 1 | 2007 | 249 | 0.060 |
Why?
|
| Glasgow Coma Scale | 2 | 2017 | 72 | 0.060 |
Why?
|
| Constipation | 1 | 2005 | 63 | 0.060 |
Why?
|
| Malaysia | 4 | 2002 | 12 | 0.060 |
Why?
|
| Peptic Ulcer | 1 | 2003 | 19 | 0.060 |
Why?
|
| Secondary Prevention | 2 | 2003 | 163 | 0.060 |
Why?
|
| Vaccination | 1 | 1985 | 270 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2009 | 780 | 0.050 |
Why?
|
| Esophagitis | 1 | 2002 | 43 | 0.050 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2000 | 393 | 0.050 |
Why?
|
| Liver Abscess | 1 | 2002 | 12 | 0.050 |
Why?
|
| Parvovirus B19, Human | 1 | 2002 | 3 | 0.050 |
Why?
|
| Heartburn | 1 | 2002 | 10 | 0.050 |
Why?
|
| Parvoviridae Infections | 1 | 2002 | 6 | 0.050 |
Why?
|
| Rabeprazole | 1 | 2001 | 1 | 0.050 |
Why?
|
| Manometry | 1 | 2002 | 44 | 0.050 |
Why?
|
| Proton-Translocating ATPases | 1 | 2001 | 23 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2002 | 45 | 0.050 |
Why?
|
| Prothrombin Time | 1 | 2001 | 20 | 0.050 |
Why?
|
| Acute Disease | 3 | 2001 | 838 | 0.050 |
Why?
|
| Bilirubin | 1 | 2001 | 130 | 0.050 |
Why?
|
| Exanthema | 1 | 2001 | 38 | 0.050 |
Why?
|
| China | 1 | 2002 | 230 | 0.050 |
Why?
|
| Albumins | 1 | 2001 | 130 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2001 | 232 | 0.050 |
Why?
|
| Prevalence | 2 | 2002 | 1248 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2005 | 2019 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 499 | 0.050 |
Why?
|
| Bismuth | 1 | 2000 | 8 | 0.050 |
Why?
|
| Diarrhea | 1 | 2001 | 182 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 2002 | 202 | 0.050 |
Why?
|
| Cadherins | 1 | 2001 | 162 | 0.050 |
Why?
|
| Endoscopy, Digestive System | 1 | 2000 | 67 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2000 | 189 | 0.040 |
Why?
|
| Herpesvirus 1, Human | 1 | 2002 | 244 | 0.040 |
Why?
|
| Pemphigoid, Benign Mucous Membrane | 1 | 1999 | 6 | 0.040 |
Why?
|
| Tetracycline | 1 | 1999 | 13 | 0.040 |
Why?
|
| Conjunctival Diseases | 1 | 1999 | 7 | 0.040 |
Why?
|
| Heart Rate | 1 | 2001 | 492 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2003 | 1716 | 0.040 |
Why?
|
| Niacinamide | 1 | 1999 | 115 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 902 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2001 | 269 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2001 | 948 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2013 | 594 | 0.040 |
Why?
|
| Mass Screening | 1 | 2002 | 631 | 0.040 |
Why?
|
| Delayed Diagnosis | 1 | 2017 | 32 | 0.040 |
Why?
|
| Edema | 1 | 2017 | 70 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 270 | 0.040 |
Why?
|
| Pneumonia | 1 | 2018 | 183 | 0.030 |
Why?
|
| Measles virus | 2 | 1985 | 14 | 0.030 |
Why?
|
| Search Engine | 1 | 2015 | 10 | 0.030 |
Why?
|
| Off-Label Use | 1 | 2015 | 16 | 0.030 |
Why?
|
| Factor Xa | 1 | 2015 | 4 | 0.030 |
Why?
|
| Recurrence | 2 | 1997 | 1168 | 0.030 |
Why?
|
| Atlanto-Axial Joint | 1 | 2015 | 8 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2016 | 46 | 0.030 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2015 | 10 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2000 | 804 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2015 | 119 | 0.030 |
Why?
|
| Morbidity | 1 | 2015 | 149 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 2015 | 54 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2015 | 111 | 0.030 |
Why?
|
| Kyphoplasty | 1 | 2014 | 7 | 0.030 |
Why?
|
| Powders | 1 | 2014 | 77 | 0.030 |
Why?
|
| Periodicals as Topic | 1 | 2016 | 168 | 0.030 |
Why?
|
| beta Catenin | 1 | 2016 | 266 | 0.030 |
Why?
|
| Neck Pain | 1 | 2013 | 18 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 1184 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2016 | 470 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2014 | 306 | 0.030 |
Why?
|
| Visual Analog Scale | 1 | 2013 | 15 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 431 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2013 | 94 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1051 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2013 | 84 | 0.030 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1996 | 294 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2015 | 331 | 0.030 |
Why?
|
| Radiculopathy | 1 | 2012 | 15 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2001 | 1520 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2013 | 129 | 0.030 |
Why?
|
| Medical Records | 1 | 2013 | 121 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2016 | 755 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 383 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 423 | 0.030 |
Why?
|
| Puberty, Delayed | 1 | 1992 | 19 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 336 | 0.030 |
Why?
|
| Hydrotherapy | 1 | 2011 | 5 | 0.030 |
Why?
|
| Histamine Antagonists | 1 | 2011 | 13 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 1187 | 0.030 |
Why?
|
| Growth Disorders | 1 | 1992 | 63 | 0.020 |
Why?
|
| Cryotherapy | 1 | 2011 | 30 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 291 | 0.020 |
Why?
|
| Asia, Southeastern | 1 | 1991 | 16 | 0.020 |
Why?
|
| Graft Survival | 1 | 2015 | 916 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 1991 | 14 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 1991 | 27 | 0.020 |
Why?
|
| Analgesics | 1 | 2011 | 119 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 1992 | 249 | 0.020 |
Why?
|
| Steroids | 1 | 2011 | 175 | 0.020 |
Why?
|
| Chicago | 1 | 2015 | 1411 | 0.020 |
Why?
|
| Pain Management | 1 | 2011 | 134 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2000 | 2536 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 770 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2002 | 684 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 2286 | 0.020 |
Why?
|
| Headache | 1 | 2007 | 72 | 0.020 |
Why?
|
| Cause of Death | 2 | 2002 | 270 | 0.020 |
Why?
|
| Lansoprazole | 1 | 2003 | 2 | 0.010 |
Why?
|
| Esophageal Stenosis | 1 | 2002 | 26 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 2002 | 89 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2002 | 55 | 0.010 |
Why?
|
| Barrett Esophagus | 1 | 2002 | 93 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2002 | 172 | 0.010 |
Why?
|
| Age Distribution | 1 | 2002 | 200 | 0.010 |
Why?
|
| Normal Distribution | 1 | 2001 | 37 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2001 | 42 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 430 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2001 | 67 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2001 | 226 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2000 | 222 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2000 | 157 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 379 | 0.010 |
Why?
|
| Comorbidity | 1 | 2002 | 947 | 0.010 |
Why?
|
| Pancreatitis | 1 | 1979 | 86 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 1843 | 0.010 |
Why?
|
| Peptic Ulcer Perforation | 1 | 1976 | 3 | 0.010 |
Why?
|
| Pyloric Stenosis | 1 | 1976 | 8 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 1976 | 59 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 1402 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1996 | 706 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 27233 | 0.010 |
Why?
|
| Smoking | 1 | 1976 | 618 | 0.010 |
Why?
|
| Gastroscopy | 1 | 1989 | 24 | 0.010 |
Why?
|